Michael R. Megna, Chief Accounting Officer: Kiniksa Pharmaceuticals International KNSA Sell · Filed 24/01/04

Trade details

Type: Insider sale
Amount: $319,563.9
Shares · price: 16,670 sh · $19.17 a share
Held after: 17,005 sh
Stock: Kiniksa Pharmaceuticals International KNSA
Person: Michael R. MegnaChief Accounting Officer
Trade date: 24/01/02
Filed: 24/01/04
Days to filing: 2 days

Sold 49.5% of holdings

Share of holding sold: 49.5%

Kiniksa Pharmaceuticals International trades, last 26 weeks

What else happened in Kiniksa Pharmaceuticals International around then

Filed or reported within 30 days of the trade day · 23/12/03~24/02/01

Michael R. Megna's recent trades

Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$369.4K
4,600 sh
$369.4K
Filed 09/03
Traded 09/03
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/13
Traded 04/09
Michael R. MegnaChief Accounting Officer
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$309.3K
6,625 sh
$309.3K
Filed 04/09
Traded 04/09
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$1.4M
37,255 sh
$1.4M
Filed 25/10/22
Traded 25/10/20
Michael R. MegnaChief Accounting Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$520.3K
13,235 sh
$520.3K
Filed 25/10/22
Traded 25/10/20